Analysts/Institutional Investor Meet/Con. Call Updates

Date: September 17, 2026 BSE Limited (‘BSE’) National Stock Exchange of India Ltd Listing Department Exchange Plaza, Corporate Relationship Department B a n d r a-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai 400 051 2nd Floor, Dalal Street, Symbol: MOLBIO Mumbai – 400 001 BSE Script Code: 544866 Subject: Intimation of Analysts/Investors call under Regulation 30 and all other applicable regulations, if any, of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the officials of the Company’s will be interacting with few investors / analysts as per the details provided below: Date Mode Type of meeting Time September 22, 2026 Group meeting /Group of 11.00 A.M. Virtual (Tuesday) Investors meeting (IST)onwards During the meeting with investors/analysts no unpublished price sensitive information (“UPSI”) shall be disclosed which is not already available in public domain. The discussion would be based on the general business outlook and information which is already in public domain. The schedule of the above-mentioned Investor meeting is subject to change due to exigencies on either side. The above disclosure is also being made available on the website of the Company at https://www.molbiodiagnostics.com. You are requested to kindly take the same on record. Thanking You. Yours Faithfully, For Molbio Diagnostics Limited Darshan Raghunath Karekar Company Secretary & Compliance Officer M.No: F13569 Place: Verna-Goa